|
Volumn 114, Issue 15, 2006, Pages
|
Letter by Safar and Fournier regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) Study" [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE;
ANTIHYPERTENSIVE AGENT;
ATENOLOL;
INDAPAMIDE;
PERINDOPRIL;
AORTA PRESSURE;
BLOOD PRESSURE REGULATION;
BRACHIAL ARTERY;
CLINICAL TRIAL;
DIASTOLIC BLOOD PRESSURE;
DRUG EFFECT;
DRUG EFFICACY;
EVALUATION;
HEART LEFT VENTRICLE EJECTION TIME;
HUMAN;
HYPERTENSION;
LETTER;
MEAN ARTERIAL PRESSURE;
OUTCOME ASSESSMENT;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
PULSE WAVE;
SYSTOLIC BLOOD PRESSURE;
ADRENERGIC BETA-ANTAGONISTS;
AMLODIPINE;
ANTIHYPERTENSIVE AGENTS;
AORTA;
ATENOLOL;
BLOOD PRESSURE;
HEART RATE;
HUMANS;
HYPERTENSION;
INDAPAMIDE;
PERINDOPRIL;
PROPORTIONAL HAZARDS MODELS;
REPRODUCIBILITY OF RESULTS;
STROKE VOLUME;
TREATMENT OUTCOME;
|
EID: 33749615671
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.106.629774 Document Type: Letter |
Times cited : (1)
|
References (5)
|